As shown in Figure 5c, of the 5 methylation sites located in the SFRP2 gene, only SFRP2‐1 could be used to distinguish CRC patients from normal individuals (AUC = 0.905). The gene discussed is SFRP2; the disease is colorectal carcinoma.